Correlation Between Agios Pharm and Kamada

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Kamada at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Kamada into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Kamada, you can compare the effects of market volatilities on Agios Pharm and Kamada and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Kamada. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Kamada.

Diversification Opportunities for Agios Pharm and Kamada

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Agios and Kamada is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Kamada in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kamada and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Kamada. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kamada has no effect on the direction of Agios Pharm i.e., Agios Pharm and Kamada go up and down completely randomly.

Pair Corralation between Agios Pharm and Kamada

Given the investment horizon of 90 days Agios Pharm is expected to generate 3.41 times less return on investment than Kamada. But when comparing it to its historical volatility, Agios Pharm is 1.19 times less risky than Kamada. It trades about 0.06 of its potential returns per unit of risk. Kamada is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  609.00  in Kamada on November 1, 2024 and sell it today you would earn a total of  65.00  from holding Kamada or generate 10.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.0%
ValuesDaily Returns

Agios Pharm  vs.  Kamada

 Performance 
       Timeline  
Agios Pharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Agios Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Kamada 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Kamada are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Kamada sustained solid returns over the last few months and may actually be approaching a breakup point.

Agios Pharm and Kamada Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agios Pharm and Kamada

The main advantage of trading using opposite Agios Pharm and Kamada positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Kamada can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kamada will offset losses from the drop in Kamada's long position.
The idea behind Agios Pharm and Kamada pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account